Ellevest Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-121
| Closed | -$12.2K | – | 1174 |
|
|
2023
Q1 | $12.2K | Buy |
121
+41
| +51% | +$4.15K | ﹤0.01% | 981 |
|
|
2022
Q4 | $9.56K | Buy |
80
+22
| +38% | +$2.63K | ﹤0.01% | 1041 |
|
|
2022
Q3 | $6K | Buy |
58
+30
| +107% | +$3.1K | ﹤0.01% | 1144 |
|
|
2022
Q2 | $3K | Buy |
28
+3
| +12% | +$321 | ﹤0.01% | 1102 |
|
|
2022
Q1 | $2K | Buy |
25
+8
| +47% | +$640 | ﹤0.01% | 1204 |
|
|
2021
Q4 | $1K | Sell |
17
-21
| -55% | -$1.24K | ﹤0.01% | 1303 |
|
|
2021
Q3 | $4K | Buy |
+38
| New | +$4K | ﹤0.01% | 1015 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$2K | – | 1296 |
|
|
2020
Q3 | $2K | Hold |
18
| – | – | ﹤0.01% | 918 |
|
|
2020
Q2 | $2K | Hold |
18
| – | – | ﹤0.01% | 899 |
|
|
2020
Q1 | $2K | Buy |
18
+11
| +157% | +$1.22K | ﹤0.01% | 780 |
|
|
2019
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 826 |
|
|
2019
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 430 |
|